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Abstract
Background: Host defense peptides (HDPs), or antimicrobial peptides (AMPs), are important
components of the innate immune system that bacterial pathogens must overcome to establish an
infection and HDPs have been suggested as novel antimicrobial therapeutics in treatment of
infectious diseases. Hence it is important to determine the natural variation in susceptibility to
HDPs to ensure a successful use in clinical treatment regimes.
Results: Strains of two human bacterial pathogens, Listeria monocytogenes and Staphylococcus
aureus, were selected to cover a wide range of origin, sub-type, and phenotypic behavior. Strains
within each species were equally sensitive to HDPs and oxidative stress representing important
components of the innate immune defense system. Four non-human peptides (protamine, plectasin,
novicidin, and novispirin G10) were similar in activity profile (MIC value spectrum) to the human
β-defensin 3 (HBD-3). All strains were inhibited by concentrations of hydrogen peroxide between
0.1% – 1.0%. Sub-selections of both species differed in expression of several virulence-related
factors and in their ability to survive in human whole blood and kill the nematode virulence model
Caenorhabditis elegans. For L. monocytogenes, proliferation in whole blood was paralleled by high
invasion in Caco-2 cells and fast killing of C. elegans, however, no such pattern in phenotypic
behavior was observed for S. aureus and none of the phenotypic differences were correlated to
sensitivity to HDPs.
Conclusion: Strains of L. monocytogenes and S. aureus were within each species equally sensitive
to a range of HDPs despite variations in subtype, origin, and phenotypic behavior. Our results
suggest that therapeutic use of HDPs will not be hampered by occurrence of naturally tolerant
strains of the two species investigated in the present study.
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Background
Antimicrobial peptides (AMPs) are widespread as bacte-
rial inactivator molecules in the innate immune systems
of insects, fungi, plants, and mammals. The peptides are
also known as host defense peptides (HDPs) as they have
other, immuno-modulatory functions besides the direct
antimicrobial actions. Three broad categories of HDPs
have been identified: the linear peptides with helical
structures (e.g. LL-37), the cysteine stabilized peptides
with beta-sheet (e.g. the defensins), and a group of linear
peptides rich in proline and arginine that primarily have
been identified in non-mammalian species [1-3].
The HDPs target a broad spectrum of bacteria [3] and
recently, these peptides have been suggested as novel anti-
microbials for treating bacterial infections [4,5]. Whilst
the peptides are regarded as universal antibacterial com-
pounds, little is known about the sensitivity spectrum of
different strains of pathogenic bacteria. Such understand-
ing would be an essential part of evaluating the potential
of HDPs in treatment.
Whilst some known pathogens possess intrinsic resistance
mechanisms indicating a central role for HDP resistance
in pathogenicity it is generally assumed that acquisition of
resistance towards a given HDP is relatively improbable
[6]. However, the spectrum of sensitivity, e.g. measured as
MIC may vary in a selection of strains that may differ in
genes known to be involved in resistance such as the dlt
operon or mprF in S. aureus [7,8]. Also, HDPs and other
components of the innate defense system may be viewed
as stress factors against which bacteria have developed
many counter protective mechanisms.
The ability of pathogenic bacteria to overcome these
defense systems is essential to establish an infection.
Strains of a particular pathogenic organism are not
equally virulent [9-12] and may also differ in sensitivity to
stresses encountered [9,13,14]. However, the resistance of
different strains to the stresses imposed by the host
defense systems might also differ and be indicative of dif-
ferences in virulence.
The purpose of the present study was to determine the
natural variation in sensitivity of strains of two pathogenic
species to host defense peptides and hydrogen peroxide.
In addition, if any differences were found, to determine if
this could be reflected by variation in the strains' pheno-
typic behavior, including expression of virulence-related
factors. Four model-peptides were chosen to represent
each of the three different peptide categories: protamine is
a linear arginine-rich peptide originally isolated from
salmon spermatozoa [15], the fungal defensin plectasin
[5], and two cathelicidins, novispirin G10 [16] and its
derivate novicidin. We used a collection of the two Gram-
positive organisms, Listeria monocytogenes and Staphylococ-
cus aureus, and selected strains carefully to reflect different
important niches of the bacteria. L. monocytogenes is a
foodborne pathogen infecting via the gastrointestinal epi-
thelia [17] and S. aureus is community- or hospital
acquired and gains access to the tissues and blood stream
whenever the skin or mucosal barrier is damaged [18]. To
ensure that the strain collection reflected a broad variation
in phenotypic behavior, we also determined the expres-
sion of several virulence factors and behavior of the bacte-
ria in simple eukaryotic models. We found that the L.
monocytogenes and S. aureus strains were within each spe-
cies equally sensitive to single components of the innate
immune defense system and this was not paralleled by
their differences in phenotypic behavior.
Methods
Strains and culture conditions
Experiments were carried out with a collection of 25 Liste-
ria monocytogenes strains (Table 1) and 16 Staphylococcus
aureus strains (Table 2) representing different lineages and
serotypes (L. monocytogenes), spa types (S. aureus), and ori-
gins (food processing environment, food products, and
human clinical isolates). Six L. monocytogenes strains were
mutants of the EGD strain and were mutated in genes
known to be involved in stress tolerance. The S. aureus col-
lection comprised two deletion mutants, strains Sa113/
ΔmprF [8] and Sa113/ΔdltA [7], known to be more sensi-
tive to host defense peptides. Two of the S. aureus strains
could not immediately be assigned to an existing spa type
and we are in the process of acquiring the additional
information that is needed to assign a new spa type to
them. The strains were obtained from The National Insti-
tute of Aquatic Resources and The National Food Insti-
tute, Technical University of Denmark, Faculty of Life
Sciences, University of Copenhagen, Denmark, Statens
Serum Institut, Denmark, University of Würzburg, Ger-
many and Campden Food and Drink Association, United
Kingdom. Stock cultures were stored at -80°C in 4% (w/
V) glycerol, 0.5% (w/V) glucose, and 2.0% (w/V)
skimmed milk powder. The bacteria were grown in Brain
Heart Infusion (BHI) broth (Oxoid, CM0225), Tryptone
Soy Broth (TSB) (Oxoid, CM129), and cation-adjusted
Mueller-Hinton II Broth (MHB) (Becton Dickinson,
212322) adjusted to pH 7.4. To avoid unspecific binding
of host defense peptides to plastic ware and agar, all MIC
determinations were carried out using polypropylene
plastic ware and radial diffusion assays were carried out in
MHB supplemented with 1% agarose (Invitrogen, 15510-
027) as gelling agent.
Host defense peptides and oxidative compounds
Protamine was purchased from Sigma (P4020-5G).
Plectasin, novicidin, and novispirin G10 were supplied by
Novozymes A/S. Recombinant HBD-3 was purchased
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Table 1: Origin, serotype, lineage, and MIC values of the Listeria monocytogenes strains used in the present study
Strain Origin Sero Lin MICa Ref
Pro Ple NoC NoS hBD H2O2
La22 CSb salmon 1/2a 2 16 128 4 64 16/16 0.23 [42]
V518a Fish processing 4b 1 32 64 8 64 - 0.94 [42]
N53-1 Fish processing 1/2a 2 16 128 2 32 16/32 0.47 [43]
No40-1 Fish processing 1/2a 2 16 128 4 64 - 0.47 [43]
R479a CS salmon 1/2a 2 16 128 4 64 - 0.47 [42]
O57 Gravad salmon 1/2a 2 16 128 4 128 - 0.47 [44]
H13-1 Fish processing 1/2a 2 16 128 4 64 - 0.94 [43]
La111 CS salmon 1/2a 2 8 64 4 32 8/16 0.94 [45]
M103-1 Fish processing 1/2a 2 32 128 4 64 - 0.94 [43]
EGD Wildtype 1/2a 2 8 64 4 64 16/16 0.47 c
2375 EGD perR del 1/2a 2 32 64 4 32 - 0.94 [46]
2374 EGD perR ins 1/2a 2 32 128 4 32 - 0.94 [46]
2275 EGD dps del 1/2a 2 16 64 4 64 - 0.94 [47]
2317 EGD prfA del 1/2a 2 16 128 4 64 - 0.94 c
2315 EGD sigB del 1/2a 2 8 64 4 64 - 0.94 [48]
2307 EGD resD del 1/2a 2 8 128 2 32 - 0.12 d
LO28 Wildtype 1/2c 2 8 64 2 16 - 0.47 [17]
4666 Human clinical 1/2b 1 8 64 8 64 - 0.18 [49]
4459 Human clinical 1/2a 2 16 128 4 32 - 0.23 [49]
7418 Spread. sausage 1/2b 1 32 64 4 64 4/8 0.18 [49]
4446 Human clinical 4b 1 16 64 4 64 16/16 0.47 [49]
6895 Ham 1/2a 2 16 128 4 96 - 0.35 [49]
7291 Pasta w chicken 4b 1 32 64 8 128 - 0.47 [49]
4239 Human clinical 1/2a 2 32 64 4 64 - 0.23 [49]
Scott A Human clinical 4b 1 16 64 4 32 8/8 N.D. e
a MIC values are given in μg/ml for the five human defense peptides and in % (V/V) for H2O2.
b CS: Cold-smoked
c The strains were kindly provided by Werner Goebel, University of Würzburg
d The strain was kindly provided by Marianne Halberg Larsen, University of Copenhagen, Faculty of Life Sciences.
e The strain was kindly provided by Campden Food and Drink Association, UK.
Table 2: Origin, spa type, and MIC values of Staphylococcus aureus strains used in the present study
Strain Origin spa MICa
Pro Ple NoC NoS hBD H2O2 Ref
8325-4 Wildtype t211 16 32 8 128 32/32 0.47 [50]
Sa113 Wildtype t211 16 32 6 128 - 0.18 [51]
ΔmprF Sa113 mprF del t211 8 4 1 8 - 0.12 [8]
ΔdltA Sa113 dltA ins t211 8 2 0.5 2 - 0.23 [7]
14943 Pork meat t012 16 8 8 256 32/64 0.23 b
15033 Pork meat t216 32 8 8 128 - 0.23 b
B31369 Human, clinical t216 16 16 12 256 64/64 0.47 b
796 Pasta salad t230 16 8 6 128 64/64 0.47 b
J15033 Human, clinical t230 16 8 8 128 - 0.23 b
2148-jvi Mastitis t518 16 1 4 64 32/32 0.47 b
K3-B2 French cheese t524 16 1 4 128 32/64 0.23 b
B29997 Human, clinical t548 16 16 4 128 - 0.23 b
KES 439 Human, clinical Ukc 32 2 4 128 - 0.23 [52]
KES 626 Human, clinical t1269 16 1 4 64 32/64 0.18 [52]
KES 735 Human, clinical Ukc 16 16 4 128 - 0.47 [52]
KES 855 Human, clinical t339 16 16 4 64 - 0.23 [52]
a MIC values are given in μg/ml for the five human defense peptides and in % (V/V) for H2O2.
b The strains were kindly provided by Jørgen Leisner, University of Copenhagen, Faculty of Life Sciences.
c Uk: Unknown.
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from PeproTech (300-52). The host defense peptides were
dissolved in 0.01% acetic acid/0.1% bovine serum albu-
min (Sigma, A7906). Hydrogen peroxide was purchased
from Bie & Berntsen (MER 1.07209.1000).
Determination of Minimum Inhibitory Concentration 
(MIC) and Minimum Bactericidal Concentration (MBC) of 
host defense peptides in liquid medium
The strain collection was tested for sensitivity to pro-
tamine, plectasin, novicidin, and novispirin G10 by deter-
mining their minimal inhibitory concentration (MIC)
using a microbroth dilution method [19]. Colonies from
a BHI agar plate incubated overnight were suspended in
MHB pH 7.4 to a turbidity of 0.11–0.12 at 546 nm
(approx. 1.0 × 108 CFU/ml) and diluted in MHB to a con-
centration of 5.0 × 105 CFU/ml. 90 μl of bacterial suspen-
sion was incubated with 10 μl of peptide solution in
polypropylene 96-well plates (Nunc, 442587) for 18–24
h at 37°C. The peptide solutions were made fresh on the
day of assay and diluted two-fold. The range of concentra-
tions assayed were 0.031–32 μg/ml for novicidin, 0.125–
128 μg/ml for protamine and novispirin G10, and 0.25–
256 μg/ml for plectasin. MIC was the lowest peptide con-
centration at which visual growth was inhibited. The min-
imum bactericidal concentration (MBC) values were
determined by plating l0 μl samples from wells with no
visible growth onto BHI agar plates. MBC was the lowest
concentration of each peptide of which 99.9% reduction
of the initial inoculum was observed.
Determination of Minimal Effective Concentration (MEC) 
of host defense peptides and H2O2 in radial diffusion assay
The MEC of HBD-3 was assayed on a sub-selection of
strains using a radial diffusion assay [20] with some mod-
ifications. In brief, MHB/1% agarose was supplemented
with glucose to an end-concentration of 0.1% (w/V) to
enhance the growth of L. monocytogenes and improve the
visualization of the inhibition zones. Bacterial suspen-
sions were prepared as described for MIC determination
in liquid medium, mixed with melted MHB pH 7.4/1%
agarose/0.1% glucose medium at 42°C to 5.0 × 106 CFU/
ml, and 10 ml gel was poured into 90 mm Petri dishes.
Following solidification on a leveling table, 1 mm wells
were punched with a Pasteur pipette. Two-fold dilutions
of HBD-3 were prepared in 0.01% acetic acid/0.1%
bovine serum albumin to a concentration range of 0.25–
256 μg/ml and 2 μl was added to each well. The plates
were incubated overnight at 37°C and MEC was deter-
mined as the lowest peptide concentration at which an
inhibition zone was observed. Each strain was tested in
two independent trials.
A similar assay was performed to determine the MEC of
hydrogen peroxide. The bacteria were prepared and mixed
with MHB/1% agarose as described above and 50 ml gel
was poured into 140 mm Petri dishes. The gel was allowed
to solidify and 3 mm wells were punched. Hydrogen per-
oxide was serially diluted from stock (30%) in Millipore
water and 10 μl was transferred to each well. The plates
were incubated overnight at 37°C and the MEC was read
as described above.
Extracellular virulence factors of S. aureus
S. aureus strains were examined for production of several
virulence factors to determine their variation in phenotypic
behavior. It was verified that all strains were S. aureus by
analyzing their production of protein A and clumping fac-
tor A using the BactiStaph identification kit (Oxoid,
R21144) as described by the manufacturer. The hemolytic
activity of S. aureus strains was determined in a microplate
hemolysin assay [21,22]. All strains were grown overnight
in BHI at 37°C with shaking and samples of the cultures
were centrifuged at 10,000 × g for 10 min. The supernatant
was treated with 10 mM dithiotreitol and 50 μl two-fold
dilutions were made in BHI in a microtiter plate with U-
formed wells. Bovine erythrocytes were washed in 0.9%
saline with 0.1% gelatin and 0.0043% sodium azide and
100 μl of a 0.5% suspension was added to the supernatant.
The plates were incubated at 37°C for 30–45 min and the
hemolytic activity was scored as follows: +++, strong hemo-
lysis; ++, moderate hemolysis; +, weak hemolysis; (+),
questionable hemolysis; -, no hemolysis. The assay was car-
ried out in duplicate. Staphylokinase activity was examined
as described earlier [23]. Plates containing fibrinogen were
prepared by dissolving human fibrinogen (Kordia, FIB 3)
in double strength TSB to a final concentration of 0.1% (w/
V). To this was added 3% (w/V) agar at 55°C and incubated
at this temperature for 10 min. Fetal bovine serum (Invitro-
gen, 10106-151) was added at 0.1% (V/V). Plates without
added serum served as controls for non-specific effects such
as might be due to high levels of protease. Isolated colonies
of each strain were then streaked onto the plates and incu-
bated overnight at 37°C. A clear zone surrounding the bac-
terial growth indicated staphylokinase activity. The assay
was repeated in two independent trials.  Catalase activity
was determined using the capillary tube catalase test as
described earlier [24]. Briefly, 3% (V/V) H2O2 were drawn
into capillary tubes (1 mm in diameter), a bacterial colony
was touched with the H2O2 tube, and the amount of gas
production was scored semiquantitatively after 10 seconds.
+(+), ++, ++(+), and +++ represent a few bubbles, moderate
number of bubbles, many bubbles, and gas forcing the 3%
H2O2 upwards in the capillary tube, respectively. Ten iso-
lated colonies were tested for each strain in two independ-
ent trials. Carotenoid production was assessed by smearing
isolated colonies on white filter paper. Finally the strains
were analyzed for production of enterotoxins A, B, C, and
D, and toxic shock syndrome toxin (TSST-1) using reversed
passive latex agglutination kits (Oxoid, TD0900 and
TD0940) as described by the manufacturer.
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S. aureus induced killing of C. elegans
For a sub-collection of S. aureus strains, the virulence was
assessed in C. elegans as described [25]. 20 μl overnight
culture of each strain was spread onto Nematode Growth
Medium (NGM) plates and incubated at 37°C over night.
For each strain, about 100 L4 hermaphrodites of the pha-
1 (e2123ts) mutant [26] were transferred from NGM
plates seeded with E. coli OP50 to the plates seeded with
staphylococci and incubated at 25°C. The plates were
scored for live and dead worms every 24 hours and 50%
mortality was taken as the time when 50% of the initial
number of worms were dead. At least three independent
trials were performed for each strain.
L. monocytogenes invasion into Caco-2 cells and induced 
killing of C. elegans
The data included are based on work presented in [27,28].
In brief, Caco-2 cells (ATCC HTB 37) for the invasion
assay were grown to monolayers in 96-well tissue culture
plates. Overnight cultures of L. monocytogenes were
adjusted to approximately 1.5 × 107 CFU/ml and allowed
to infect the Caco-2 cells for 1 hour at 37°C. Extracellular
bacteria were killed by incubation with 50 μg/ml gen-
tamicin for 1 hour at 37°C before the cells were lyzed
using 0.1% Triton X-100. The number of intracellular bac-
teria was determined by plate count. The C. elegans assay
was performed as described above for S. aureus except that
the bacteria were spread onto Luria-Bertani (LB) plates.
Human whole blood killing assay
A sub-selection of strains was tested for sensitivity to
human whole blood by incubating the individual L.
monocytogenes and S. aureus strains with blood to a final
concentration of 75%. Human blood samples were
obtained from a normal healthy volunteer by venous
puncture and collected in BD vacutainers coated with
3.8% citrate (Hettich Labinstruments Aps, 455382). Bac-
terial suspensions were prepared as described for MIC
determination and diluted in MHB to a final concentra-
tion of approximately 5.0 × 103 CFU/ml, followed by
addition of fresh human blood or peptone saline (0.1%
peptone, 0.85% NaCl) as a control. E. coli MG1655 was
used as a positive control for neutrophil-mediated killing.
The mixtures were shaken (300 rpm) at 37°C for 24
hours. To determine bacterial viability, aliquots were
withdrawn at the beginning of the assay and after 2, 4, 6,
and 24 hours of incubation and serial dilutions were
plated onto BHI agar. Each strain was tested in duplicate
in two independent trials.
Statistical analysis
Data were analyzed using GraphPad Prism Statistical soft-
ware. Data did not follow a Gaussian distribution and so
Friedman's test was used to compare strains and Kruskal-
Wallis test was used to compare groups. Dunn's post test
was used for both. If only two groups were compared, the
Mann-Whitney test was used. Since MIC and MEC values
were determined from two-fold dilutions of peptides,
these data were log2-transformed before test.
Results
MIC and MBC of HDP in liquid medium against L. 
monocytogenes and S. aureus
We compared the sensitivity of 25 L. monocytogenes strains
and 16 S. aureus strains to four model HDPs (Table 1 and
Table 2). The MIC values of the four HDPs against L.
monocytogenes were 8–32 μg/ml (protamine), 32–128 μg/
ml (plectasin), 2–8 μg/ml (novicidin), and 4–128 μg/ml
(novispirin G10). For S. aureus the range was 8–32 μg/ml
(protamine), 1–32 μg/ml (plectasin), 0.5–12 μg/ml
(novicidin), and 2->128 μg/ml (novispirin G10). Pro-
tamine appeared to be equally efficient against both L.
monocytogenes and S. aureus, while plectasin was more
active against S. aureus than L. monocytogenes. Both novici-
din and novispirin G10 were equally effective against the
two bacteria and novicidin was clearly more potent than
its parent peptide. The minimum bactericidal concentra-
tions (MBC) of plectasin, novicidin, and novispirin G10
were identical to the MICs, suggesting that all three pep-
tides have pronounced bactericidal effects.
The two peptide-sensitive S. aureus mutants (SA113/
ΔmprF and SA113/ΔdltA) were, logically, more sensitive
than the rest of the strains but otherwise there was no sig-
nificant differences in peptide sensitivity between neither
L. monocytogenes (p = 0.0718) nor S. aureus (p = 0.0647).
Some differences were found between L. monocytogenes
lineages in tolerance to single peptides (lineage 1 strains
were more sensitive to plectasin, p = 0.01, and lineage 2
strains were more sensitive to novicidin, p = 0.0334), but
there was no difference in tolerance between lineages to
all the four peptides together (p = 0.4627). Likewise, no
significant differences were found when the strains were
grouped according to origin (clinical, food, and process-
ing), suggesting that there is no systematic differences in
peptide tolerance between the strains.
No systematic differences in MEC values of human β-
defensin 3 between strains
A sub-selection of strains was tested against the human
host defense peptide β-defensin 3 (HBD-3) to compare
the activity spectrum to the four model-peptides. HBD-3
was originally identified in skin and is also expressed in
epithelial cells lining the digestive tract and is active
towards Gram-positive bacteria [29]. It is therefore highly
relevant when examining both L. monocytogenes and S.
aureus. The MEC values varied between 6 and 24 μg/ml for
L. monocytogenes and 32 and 64 μg/ml for S. aureus (Tables
1 and 2). As for the non-human model-peptides, there
was no systematic variation in MEC values when the
BMC Microbiology 2008, 8:205 http://www.biomedcentral.com/1471-2180/8/205
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strains were grouped according to origin for neither L.
monocytogenes (p = 0.2276) nor S. aureus (p = 0.2899). The
MEC spectrum of HBD-3 was similar to the four non-
human peptides.
MEC of hydrogen peroxide against L. monocytogenes 
and S. aureus in radial diffusion assay
The susceptibility of the strains to an oxidative burst gen-
erated by hydrogen peroxide was assayed by a radial diffu-
sion assay (Tables 1 and 2). MEC values were in the range
of 0.12–0.94% (V/V) against L. monocytogenes and 0.12–
0.47% (V/V) against S. aureus. As was the case with the
HDPs no systematic difference in tolerance between
strains could be observed when grouped according to ori-
gin for neither L. monocytogenes (p = 0.0571) nor S. aureus
(p = 0.5225). Also, there was no difference in tolerance
between L. monocytogenes lineage 1 and 2 strains (p =
0.1491).
Determination of virulence factor expression and 
phenotypic behavior in L. monocytogenes and S. aureus 
strains
To address if differences in peptide sensitivity among
strains reflect their virulence potential, it is necessary to
have a collection of strains that represent a wide spectrum
of virulence factor expression. We have previously shown
that the L. monocytogenes strains used in the present study
differ in behavior in several virulence factor assays. The
strains varied in their ability to invade Caco-2 cells and in
their killing kinetics against C. elegans [27,28]. A sub-collec-
tion of strains (Table 3) was selected for the present study
to span the different behavior in the virulence models.
To select a similar representative sub-collection of S.
aureus strains, each strain was analyzed for several extra-
cellular virulence factors (Table 4).
The two HDP-sensitive mutants had significantly lower
virulence factor expression than the rest (p = 0.0299),
which could indicate that intrinsic HDP tolerance may be
related to virulence of pathogenic bacteria. The rest of the
strains varied in the expression of the individual virulence
factors but no clear patterns in phenotypic behavior were
found.
For instance, the clinical strains were not more hemolytic
than the rest of the strains (p = 0.4676) consistent with
reports on clinical strains without hemolytic activity
[30,31]. In this study an animal clinical strain, 2148-jvi,
was found to be non-hemolytic and two human clinical
strains, KES 439 and KES 735, were only weakly hemo-
lytic. Likewise, there was no correlation between the pro-
duction of catalase and carotenoid (r = 0.444, p = 0.085),
suggesting that these oxidative attack defense mechanisms
contribute differently in each strain.
Three strains produced enterotoxins and only one of
these, strain 14943, produced both enterotoxin A and
TSST-1.
Seven strains were selected to represent different expres-
sion levels of the virulence factors and different strain ori-
gin. These were analyzed for their killing kinetics in a C.
elegans worm model. The seven S. aureus strains killed the
C. elegans more rapidly than the negative control strain E.
Table 3: Virulence assessment and survival in whole blood of a sub-collection of L. monocytogenes strains
Strain Invasion Caco-2 (CFU/ml) 50% mortality C. elegans (hours) Cell density Whole blood (CFU/ml)
La22 1.4 × 105 - 6.4 × 103
V518a 3.8 × 105 - -
N53-1 1.9 × 102 110 1.3 × 103
No40-1 1.1 × 105 - -
R479a 2.4 × 104 - -
O57 4.1 × 104 - -
H13-1 5.5 × 102 - -
La111 4.1 × 102 110 2.9 × 102
M103-1 1.9 × 102 - -
EGD 2.1 × 104 110 1.3 × 103
LO28 5.3 × 103 - -
4666 3.1 × 105 - -
4459 8.5 × 104 - -
7418 2.8 × 105 80 2.8 × 104
4446 1.2 × 105 80 4.3 × 104
6895 3.3 × 104 - -
7291 2.6 × 105 - -
4239 1.9 × 104 - -
Scott A 2.8 × 105 80 9.0 × 102
Data on Caco-2 cell invasion and C. elegans mortality based on [27,28].
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coli OP50 (Figure 1 and Table 4). The strains differed with
respect to the time taken to reach 50% mortality of the
worms. When feeding on the two fastest killers, the
human clinical strains KES 626 and B31369, the worms
reached 50% mortality in 118 and 140 hours respectively.
The three food isolates 14943, 796, and K3-B2 resulted in
50% mortality after 157 hours, 223 hours, and 225 hours
respectively. Feeding on the laboratory reference strain
8325-4 took 184 hours to reach 50% mortality, while the
mastitis isolate 2148-jvi led to 50% mortality in 256
hours.
Difference in ability to survive and grow in whole blood
A sub-collection of strains was examined for their behav-
ior in human whole blood to analyze the response of
these strains to a more complex model of the innate
immune system. The strains were chosen on the basis of
their origin and their behavior in the virulence factor
assays described above (Table 3 and Table 4).
All seven L. monocytogenes strains were able to survive in
human whole blood for 24 hours (Figure 2A). Strains
EGD and Scott A remained at approximately the same cell
number during the 24 hours of incubation, whereas the
strains N53-1 and La111 grew during the first four hours
of incubation and thereafter declined to the inoculation
level or just below. The last three strains grew throughout
the experiment. La22 increased approximately half a log
unit and both 7418 and 4446 grew to approximately one
log unit over inoculation level. The ability to grow and/or
survive in whole blood was to some extent paralleled by
the ability of the strains to invade Caco-2 cells and kill C.
elegans worms. Thus, the better the survival or growth, the
higher the invasion into Caco-2 cells and mortality in C.
elegans. 7418 and 4446 both grew well in whole blood,
were highly invasive in Caco-2 cells, and killed 50% of the
C. elegans worms in 80 hours. Likewise, N53-1 and La111
whose cell numbers were declining in whole blood both
were low invasive in Caco-2 cells and took 110 hours to
kill 50% of the worms. For La22, EGD, and Scott A there
Table 4: Virulence assessment of the S. aureus strain collection
Strain Hemolysis Staph. kin. Catalase Carotenoid Enterotoxin TSST-1 C. elegans Blood
A B C D
8325-4 +++ - a ++ + - - - - - 184 2.4 × 108
Sa113 - - ++ ++ - - - - -
ΔmprF - - ++(+) ++ - - - - -
ΔdltA - - +(+) + - - - - -
14943 - - ++(+) +++ +++ - - - +++ 157 7.6 × 108
15033 ++ - +++ +++ - +++ - - -
B31369 ++ - ++(+) +++ - +++ - - - 140 1.1 × 108
796 (+) - ++(+) +++ - - - - - 223 2.5 × 108
J15033 (+) - ++ +++ - - - - -
2148-jvi - - ++(+) ++ - - - - - 256 3.0 × 106
K3-B2 + - ++ ++ - - - - - 225 3.4 × 107
B29997 (+) - ++(+) +++ - - - - -
KES439 (+) - ++ ++ - - - - -
KES626 +++ - a ++(+) + - - - - - 118 1.0 × 109
KES735 (+) - ++ +++ - - - - -
KES855 ++ - ++ ++ - - - - -
a A clearing zone on both plates with and without added serum indicate a high production of proteases.
Tests include hemolytic activity, staphylokinase activity, catalase activity, carotenoid production and production of exotoxins. A sub-selection of 
strains were tested for their killing kinetics against C. elegans (time to 50% mortality, h) and their ability to survive and grow in human whole blood 
(cell density after 24 h, CFU/ml).
Assessment of virulence of a sub-selection of S. aureus strains again t C. elegansFigure 1
Assessment of virulence of a sub-selection of S. 
aureus strains against C. elegans. 100 pha-1 mutant 
worms were tested for each strain. % mortality indicates the 
number of dead worms relative to the starting number of 
worms. Error bars represent standard deviations of triplicate 
measures.
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was not a clear pattern. There was a correlation between
the invasive ability in Caco-2 and the lethality in C. elegans
(r = -0.891, p = 0.033) but the survival in whole blood
could not be correlated to neither Caco-2 invasion (r =
0.327, p = 0.498) nor C. elegans (r = -0.495, p = 0.356).
All seven S. aureus strains both survived and grew in whole
blood (Figure 2B). Six of the strains had nearly identical
growth patterns. KES 626 was the strain that reached the
highest cell density (1.0 × 109 CFU/ml) after 24 hours.
This was also the strain that killed the C. elegans worms
the fastest. 2148-jvi grew remarkably poorer than the rest
and reached a cell density of only 3.0 × 106 CFU/ml after
24 hours. When C. elegans fed on 2148-jvi, 50% mortality
was not reached until after 256 hours compared to 118
hours for KES 626. There was however, no statistical cor-
relation between killing time in C. elegans and survival in
whole blood for the seven strains (r = -0.750, p = 0.066).
Together, the C. elegans and whole blood assays do not
identify more virulent strains but they do indicate that the
strains differ in phenotypic behavior.
Discussion
In the present study, we found that antimicrobial compo-
nents of the innate immune defense (HDPs and hydrogen
peroxide) act equally well on several strains of two patho-
genic bacterial species (Table 1 and 2). We did not find
significant inter-strain differences in sensitivity to neither
the HDPs nor hydrogen peroxide. In general, the S. aureus
strains were more sensitive to plectasin than L. monocy-
togenes, which is in concordance with previous findings
[5]. The four non-human model peptides represent each
of the three classes of host defense peptides and were sim-
ilar in MIC spectrum to HBD-3.
Generally, L. monocytogenes strains from clinical cases are
more virulent than strains isolated from environmental
sources such as food [32]. Therefore, one could expect that
the clinical isolates would be more tolerant to HDPs or
hydrogen peroxide. However, no consistent patterns in
tolerance were observed when the strains were grouped
according to their origin.
The lack of difference between L. monocytogenes strains to
the eukaryotic cationic peptides tested here is in contrast
to the differences in sensitivity of strains to the bacterial
cationic peptides, bacteriocins, that have been observed in
several studies [33-35]. The differences could, however,
not be correlated to neither strain origin [33] nor serovar
[35] and may simply reflect the natural variation within
the bacterial population.
There was no similarity in the S. aureus strains' perform-
ance in the virulence factor assays and their tolerance to
the antimicrobial compounds of the innate immune
defense system. Compared to L. monocytogenes, the disease
spectrum of S. aureus is more complex. To assess the dif-
ferences in phenotypic behavior of the S. aureus strains in
parallel to the data we have obtained earlier for L. monocy-
togenes [27,28], we analyzed the S. aureus strains for sev-
eral virulence factors that all contribute to evasion of the
neutrophil attack at the site of infection [36]. There was
considerably variation between the S. aureus strains for
each of the single virulence factors tested in this study.
However, none of the strains could be identified as gener-
ally more or less virulent than the rest and probably reflect
that each strain is more or less specialized or virulent in
one (or more) type(s) of infection(s).
The growth of L. monocytogenes and S. aureus strains in
human whole blood and lethality in C. elegans demon-
strated that the strains differed in growth in such eukaryo-
tic systems but this could not be matched to tolerance to
Survival of selected L. monocytogenes (A) and S. aureus (B) strains in human whole bloodFigure 2
Survival of selected L. monocytogenes (A) and S. 
aureus (B) strains in human whole blood. Strains were 
adjusted to 1.0 × 103 CFU/ml, mixed 1:3 with human whole 
blood, and incubated at 37°C. E. coli MG1655 was used as a 
positive control for neutrophil killing. Bars represent stand-
ard deviations of duplicate observations. Graphs are repre-
sentative of two independent experiments. Arrows indicate 
that cell numbers were below the detection limit (1.0 × 101 
CFU/ml).
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host defense peptides or hydrogen peroxide. Likewise,
there was no statistical correlation between the growth of
L. monocytogenes in whole blood and the invasive ability in
Caco-2 cells [27] or the lethality in C. elegans [28]. The
ability of S. aureus to grow in human whole blood was not
paralleled by any of the virulence parameters tested here.
Liu and co-workers showed that disruption of the carote-
noid biosynthesis impaired the resistance to both neu-
trophil and whole blood killing [37]. We found that strain
2148-jvi which had an intermediate carotenoid produc-
tion grew poorly in human whole blood, whereas both
8325-4 and KES 626 which had a low carotenoid produc-
tion grew very well in whole blood. There was no correla-
tion between the S. aureus strains' growth in whole blood
and their lethality in C. elegans, although the best and the
poorest survivor (KES 626 and 2148-jvi, respectively) also
were the fastest and the slowest to kill the worms. Blood
from different donors may have different bactericidal
activity and we initially compared the sensitivity of L.
monocytogenes EGD to blood from three donors. The strain
was equally sensitive to all three and the experiments were
therefore performed with blood from only one donor.
The HDPs are widespread as a diverse and very well-con-
served part of the defense system in all eukaryotes and
have retained their antimicrobial activity for millions of
years, hence the acquisition of resistance towards HDPs is
considered unlikely. This has prompted the use of the
design principles of these molecules for the design of new
anti-infective drugs [3,38]. Indeed, several novel HDPs
have been discovered and are thought to represent one of
the most innovative families of anti-infective agents that
have been characterized over the last 25 years [4,5]. In
addition, HDPs have also been suggested as natural alter-
natives to chemical food preservatives [39-41].
Our data indicate that such host defense peptides would
be well suited for both purposes as they appeared to have
broad bactericidal effect on human pathogenic bacteria
with different expression patterns of virulence factors. The
lack of natural strains with a particular high tolerance to
the peptides indicates that they are likely to be effective
independently of the particular strain causing the infec-
tion.
Conclusion
We found that a collection of L. monocytogenes and S.
aureus strains did not differ in tolerance to single compo-
nents of the innate immune system despite representing a
broad spectrum of phenotypically different organisms.
Four non-human host defense peptides were similar in
activity profile (MIC value spectrum) to the human HBD-
3 when examined against a sub-selection of strains. When
the same sub-selection was tested in human whole blood
and C. elegans worms, differences between strains were
found in each assay but there was no correlation between
the two models. The broad activity of the HDPs against
several strains of a pathogenic species indicates that natu-
ral resistance is not present in a population and these
HDPs may indeed, as suggested, be useful as novel antimi-
crobials.
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